Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
[This corrects the article DOI: 10.1371/journal.pone.0245481.].
Guardado en:
Autores principales: | Ji Bak Kim, Woo Hyuk Song, Jong Sung Park, Tae-Jin Youn, Yong Hyun Park, Shin-Jae Kim, Sung Gyun Ahn, Joon-Hyung Doh, Yun-Hyeong Cho, Jin Won Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9350a809b1d84ea5af95fe89f43132b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Atorvastatin-mediated rescue of cancer-related cognitive changes in combined anticancer therapies.
por: Junho Lee, et al.
Publicado: (2021) -
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg?
por: Sung Soo Kim MD, et al.
Publicado: (2021) -
Author Correction: Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
por: Janghee Lee, et al.
Publicado: (2021) -
A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alpha) vs. Eprex® in patients with anaemia of chronic renal failure
por: Soo Kun Lim, et al.
Publicado: (2021) -
Large diameter scleral lens benefits for Asians with intractable ocular surface diseases: a prospective, single-arm clinical trial
por: Jayoon Moon, et al.
Publicado: (2021)